Patient Experience of Oral Sunitinib(Sutent®)

• Research type

  Research Study

• Full title

  Exploring the patient’s experience of oral Sunitinib (Sutent®) therapy for advanced (aRCC) or metastatic renal cell carcinoma (mRCC).

• IRAS ID

  118734

• Contact name

  Theresa Wiseman

• Contact email

  theresa.wiseman@rmh.nhs.uk

• Sponsor organisation

  The Royal Marsden NHS Foundation Trust

• REC name

  West Midlands - Coventry & Warwickshire Research Ethics Committee

• REC reference

  13/WM/0185

• Date of REC Opinion

  26 Apr 2013

• REC opinion

  Favourable Opinion